These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM. Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [Abstract] [Full Text] [Related]
5. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J. Int J Cancer; 2014 Mar 15; 134(6):1389-98. PubMed ID: 23929250 [Abstract] [Full Text] [Related]
6. Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa. Clifford GM, de Vuyst H, Tenet V, Plummer M, Tully S, Franceschi S. J Acquir Immune Defic Syndr; 2016 Nov 01; 73(3):332-339. PubMed ID: 27331659 [Abstract] [Full Text] [Related]
7. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status]. Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF. Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846 [Abstract] [Full Text] [Related]
9. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China. Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z. Medicine (Baltimore); 2016 Jan 23; 95(3):e2555. PubMed ID: 26817906 [Abstract] [Full Text] [Related]
11. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay. Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X. Int J Gynecol Cancer; 2013 Mar 23; 23(3):527-32. PubMed ID: 23392403 [Abstract] [Full Text] [Related]
13. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. Vintermyr OK, Iversen O, Thoresen S, Quint W, Molijn A, de Souza S, Rosillon D, Holl K. Gynecol Oncol; 2014 May 23; 133(2):159-66. PubMed ID: 24631451 [Abstract] [Full Text] [Related]
17. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases. Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C. Cancer Cytopathol; 2022 Jul 23; 130(7):542-550. PubMed ID: 35312217 [Abstract] [Full Text] [Related]
18. High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020. Boni SP, Tenet V, Horo A, Heideman DAM, Bleeker MCG, Tanon A, Mian B, Mohenou ID, Ekouevi DK, Gheit T, Didi-Kouko Coulibaly J, Tchounga BK, Adoubi I, Clifford GM, Jaquet A, on behalf The IeDEA West Africa Collaboration. Int J Cancer; 2024 Mar 15; 154(6):962-968. PubMed ID: 37942579 [Abstract] [Full Text] [Related]
19. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study. Wu P, Xiong H, Yang M, Li L, Wu P, Lazare C, Cao C, Gao P, Meng Y, Zhi W, Lin S, Hu J, Wei J, Ma D, Liu J, Yin P, Xing H. Gynecol Oncol; 2019 Dec 15; 155(3):436-443. PubMed ID: 31604662 [Abstract] [Full Text] [Related]